IDXX Q2 2022 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q2 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$861M+4.2% YoY

Gross Profit

$514M59.7% margin

Operating Income

$179M20.8% margin

Net Income

$132M15.3% margin

EPS (Diluted)

$1.56

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$66M

Free Cash Flow

$36M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$2.2B

Stockholders' Equity

$457M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$861M	$826M	+4.2%
Gross Profit	$514M	$489M	+5.1%
Operating Income	$179M	$259M	-30.9%
Net Income	$132M	$203M	-34.9%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$3.0B98%

Reagent Rental Programs

$36M1%

Extended Warranties And Post Contract Support

$13M0%

Instrument Rebate Programs

$3M0%

Geographic Segments

UNITED STATES

$560M65%

EMEA

$162M19%

Asia Pacific

$80M9%

CANADA

$40M5%

Latin America

$19M2%